Products - Ear, nose and throat conditions | Topic

Showing 8 products

Date | Title

STG320 for treating allergic rhinitis or rhinoconjunctivitis caused by house dust mites [ID1278]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tinnitus
Status:
Awaiting development
Expected publication date:
TBC
Sleep disordered breathing
Status:
Awaiting development
Expected publication date:
TBC
Adults with lifelong or very severe hearing or visual impairment: health, well-being and social care
Status:
Awaiting development
Expected publication date:
TBC
Benralizumab for previously treated severe nasal polyps [ID1659]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps TS ID 11918
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Depemokimab for treating chronic rhinosinusitis with nasal polyps ID 6449
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen in people 5 to 17 years TSID 12054
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC